Suppression of human colorectal carcinoma cell growth by wild-type p53.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Science

• Publication date

  1990-08-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.2144057PMID 2144057
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.

  1990cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia.

  1990cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene

  1989cited by this paper
• At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma.

  1989cited by this paper
• Multiple genetic alterations in distal and proximal colorectal cancer.

  1989cited by this paper
• Wild-type p53 can inhibit oncogene-mediated focus formation.

  1989cited by this paper
• Instability of extrachromosomal cosmid DNA in SV40-transformed human (ataxia-telangiectasia) cells.

  1989cited by this paper
• Allelotype of colorectal carcinomas.

  1989cited by this paper
• Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.

  1989cited by this paper
• Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

  1989cited by this paper
• The p53 proto-oncogene can act as a suppressor of transformation.

  1989cited by this paper
• Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells

  1988cited by this paper
• Clonal genomic alterations in glioma malignancy stages.

  1988cited by this paper
• Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia.

  1988cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line

  1988cited by this paper
• Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

  1988cited by this paper
• Allele loss on short arm of chromosome 17 in breast cancers.

  1988cited by this paper
• Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.

  1988cited by this paper
• SV 40-transformed normal and DNA-repair-deficient human fibroblasts can be transfected with high frequency but retain only limited amounts of integrated DNA.

  1988cited by this paper
• Clonal analysis of human colorectal tumors.

  1987cited by this paper
• Inhibition of cell growth mediated by plasmids encoding p53 anti-sense.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

  1987cited by this paper
• Differences between rodent and human cell lines in the amount of integrated DNA after transfection.

  1987cited by this paper
• Rearrangement of the p53 gene in human osteogenic sarcomas.

  1987cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Cell culture of human colon adenomas and carcinomas.

  1987cited by this paper
• Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

  1986cited by this paper
• Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells.

  1986cited by this paper
• Patterns of integration of exogenous DNA sequences transfected into mammalian cells of primate and rodent origin.

  1986cited by this paper
• A method to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c-Ki-ras allele in human tumor cells.

  1985cited by this paper
• Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

  1985cited by this paper
• Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes.

  1985cited by this paper
• Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

  1984cited by this paper
• Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies

  1984cited by this paper

• The p53 tumor suppressor modulates the expression of proteins that control natural killer cell activity.

  2026cites this paper
• A base editing platform for the correction of cancer driver mutations unmasks conserved p53 transcription programs

  2025cites this paper
• Targeting p53 for Immune Modulation: Exploring Its Functions in Tumor Immunity and Inflammation.

  2025cites this paper
• The HPV101 E7 protein shares host cellular targets and biological activities with high-risk HPV16 E7

  2024cites this paper
• The Strong Activation of p53 Tumor Suppressor Drives the Synthesis of the Enigmatic Isoform of DUSP13 Protein

  2024cites this paper
• Apoptotic effects of Acorus calamus extract on prostate cancer LNCaP cells

  2024cites this paper
• Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes.

  2024cites this paper
• The Capicua C1 Domain Is Required for Full Activity of the CIC::DUX4 Fusion Oncoprotein

  2024cites this paper
• The Capicua C1 Domain is Required for Full Activity of the CIC::DUX4 Fusion Oncoprotein

  2024cites this paper
• Reconstructing the functional effect of TP53 somatic mutations on its regulon using causal signalling network modelling

  2023cites this paper
• Multiple Protein Biomarkers and Different Treatment Strategies for Colorectal Carcinoma: A Comprehensive Prospective.

  2023cites this paper
• Tumor-suppressive role of the musculoaponeurotic fibrosarcoma gene in colorectal cancer.

  2023cites this paper
• TRRAP Enhances Cancer Stem Cell Characteristics by Regulating NANOG Protein Stability in Colon Cancer Cells

  2023cites this paper
• MmuPV1 E7’s interaction with PTPN14 delays Epithelial differentiation and contributes to virus-induced skin disease

  2023cites this paper
• BLM helicase overexpressed in human gliomas contributes to diverse responses of human glioma cells to chemotherapy

  2023cites this paper
• Genome-guided discovery of cancer therapeutic targets.

  2023cites this paper
• A machine learning and directed network optimization approach to uncover TP53 regulatory patterns

  2023cites this paper
• Photoprotective Effects of Dendrobium nobile Lindl. Polysaccharides against UVB-Induced Oxidative Stress and Apoptosis in HaCaT Cells

  2023cites this paper
• Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells

  2023cites this paper
• GADD34 activates p53 and may have utility as a marker of atherosclerosis

  2023cites this paper
• Fatty acids and their lipid mediators in the induction of cellular apoptosis in cancer cells.

  2022cites this paper
• A comprehensive study of p53 protein

  2022influential citation
• p53 Regulates a miRNA-Fructose Transporter Axis in Brown Adipose Tissue Under Fasting

  2022cites this paper
• FOXO transcription factors differ in their dynamics and intra/intermolecular interactions

  2022cites this paper
• Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC

  2022cites this paper
• Paradoxical tumor suppressive role of the musculoaponeurotic fibrosarcoma gene in colorectal cancer

  2022cites this paper
• Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis

  2022influential citation
• Computational analysis uncovers the deleterious SNPs along with the mutational spectrum of p53 gene and its differential expression pattern in pan-cancer

  2022cites this paper
• Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53

  2022cites this paper
• ROS-activated CXCR2+ neutrophils recruited by CXCL1 delay denervated skeletal muscle atrophy and undergo P53-mediated apoptosis

  2022cites this paper
• PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer

  2021cites this paper
• Viral targeting of glioblastoma stem cells with patient-specific genetic and post-translational p53 deregulations.

  2021cites this paper
• Status of microsatellite instability in different histomorphological patterns of colorectal carcinoma among a group of Bangladeshi people

  2021cites this paper
• Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity

  2021cites this paper
• Chemical rescue of mutant proteins in living Saccharomyces cerevisiae cells by naturally occurring small molecules

  2021cites this paper
• Spontaneous and inherited TP53 genetic alterations

  2021cites this paper
• The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis

  2021cites this paper
• The Mus musculus papillomavirus type 1 E7 protein binds to the retinoblastoma tumor suppressor - implications for viral pathogenesis

  2021cites this paper
• Chemical rescue of mutant proteins in living cells by naturally occurring small molecules

  2021cites this paper
• TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells

  2021cites this paper
• Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis

  2021cites this paper
• Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation

  2021cites this paper
• Dying to Survive—The p53 Paradox

  2021cites this paper
• Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors

  2021cites this paper
• Novel modulators of p53-signaling encoded by unknown genes of emerging viruses

  2021cites this paper
• Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair

  2021cites this paper
• Co nás učí nádory. Paralely v chování buněk a lidí

  2021cites this paper
• The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation

  2021cites this paper
• p53: 800 million years of evolution and 40 years of discovery

  2020cites this paper
• Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer

  2020cites this paper
• Introduction to Genes, Oncogenes, and Anti-oncogenes

  2020cites this paper
• Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter

  2020cites this paper
• Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity

  2020cites this paper
• The Effect of a Newly Synthesized Ferrocene Derivative AGAINST MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.

  2020cites this paper
• Characterization of LGR5 expression in poorly differentiated colorectal carcinoma with mismatch repair protein deficiency

  2020cites this paper
• Discovery of the PTEN Tumor Suppressor and Its Connection to the PI3K and AKT Oncogenes.

  2020cites this paper
• Transgenic zebrafish for modeling hepatocellular carcinoma

  2020cites this paper
• CMAR_A_259677 7305..7317

  2020cites this paper
• Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates

  2020cites this paper
• HSATII RNA is induced via a non-canonical ATM-regulated DNA-damage response pathway and facilitates tumor cell proliferation and movement

  2020cites this paper
• Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear Accumulations

  2020cites this paper
• Clinical aspects of Lynch syndrome

  2020cites this paper
• Allicin Inhibits Proliferation by Decreasing IL-6 and IFN-β in HCMV-Infected Glioma Cells

  2020cites this paper
• Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers

  2020cites this paper
• Regulation of MYO18B mRNA by a network of C19MC miRNA-520G, IFN-γ, CEBPB, p53 and bFGF in hepatocellular carcinoma

  2020cites this paper
• Non-Random Selection of Cancer-Causing Mutations in Tissue-Specific Stem Cells Cause Cancer.

  2020cites this paper
• n-Hexane Extract of Mangrove Leaves Effect on p21 and Akt 2 Gene Expressions of WiDr Cells

  2019cites this paper
• Abrogation of FBW7α-dependent p53 degradation enhances p53's function as a tumor suppressor

  2019cites this paper
• A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies

  2019cites this paper
• Design and Synthesis of New Substituted Spirooxindoles as Potential Inhibitors of the MDM 2 − p 53 Interaction

  2019cites this paper
• The Roles of Initiating Truncal Mutations in Human Cancers: The Order of Mutations and Tumor Cell Type Matters.

  2019cites this paper
• The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line

  2019cites this paper
• Study of immunohistochemical expression of P53 In colorectal carcinoma

  2019cites this paper
• The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer

  2019cites this paper
• p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition

  2019cites this paper
• Engineering megakaryocytic microparticles for nucleic acid delivery and their biological effects to hematopoietic stem/progenitor cells

  2019cites this paper
• From birds to drug-resistant cancer : a novel in situ methodology to explore divergent genome evolution

  2019cites this paper
• The many faces of p53: something for everyone

  2019cites this paper
• Transfection with p21 and p53 tumor suppressor plasmids suppressed breast tumor growth in syngeneic mouse model.

  2019cites this paper
• Effect of NOP2 knockdown on colon cancer cell proliferation, migration, and invasion

  2019cites this paper
• Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction.

  2019cites this paper
• Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis

  2019cites this paper
• Small size, big impact: how studies of small DNA tumour viruses revolutionized biology

  2019cites this paper
• Immunohistochemical P 53 Protein Expression in Advanced Colorectal Cancer Lesions : No Association with Prognostic Variables or Survival

  2018cites this paper
• The secondary Fusarium metabolite aurofusarin induces oxidative stress, cytotoxicity and genotoxicity in human colon cells.

  2018cites this paper
• The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein.

  2018cites this paper
• Kobe University Repository : Kernel タイトル Tit le Immunohistochemical P 53 Protein Expression in Advanced Colorectal Cancer Lesions : No Associat ion with Prognost ic Variables or Survival

  2018cites this paper
• Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis

  2018cites this paper
• Robust Enhancement of Lentivirus Production by Promoter Activation

  2018cites this paper
• Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells

  2018cites this paper
• Prediction of Deleterious Single Nucleotide Polymorphisms in Human p53 Gene

  2018cites this paper
• Centrosome amplification arises before neoplasia and increases upon p53 loss in tumorigenesis

  2018influential citation
• Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy

  2018cites this paper
• Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro

  2018cites this paper
• Chemical modulation of transcription factors.

  2018cites this paper
• Antiproliferative effects of the CDK6 inhibitor PD0332991 and its effect on signaling networks in gastric cancer cells

  2018cites this paper
• A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation

  2018influential citation
• A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.

  2018cites this paper
• Protein Sensing Beyond the Debye Length Using Graphene Field-Effect Transistors

  2018cites this paper
• Design of Novel Putative Peptide fragments derived from exons of p53 isoform g and p53 promoter region ORF sequence targeting HDM2/MDM2-p53 interaction

  2018cites this paper